Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Neural stem cell-based dual suicide gene delivery for metastatic brain tumors

Abstract

In our previous works, we demonstrated that human neural stem cells (NSCs) transduced with the cytosine deaminase (CD) gene showed remarkable ‘bystander killer effect’ on glioma and medulloblastoma cells after administration of the prodrug 5-fluorocytosine (5-FC). In addition, herpes simplex virus thymidine kinase (TK) is a widely studied enzyme used for suicide gene strategies, for which the prodrug is ganciclovir (GCV). To apply this strategy to brain metastasis treatment, we established here a human NSC line (F3.CD-TK) expressing the dual suicide genes CD and TK. We examined whether F3.CD-TK cells intensified the antitumor effect on lung cancer brain metastases. In vitro studies showed that F3.CD-TK cells exerted a marked bystander effect on human lung cancer cells after treatment with 5-FC and GCV. In a novel experimental brain metastases model, intravenously administered F3 cells migrated near lung cancer metastatic lesions, which were induced by the injection of lung cancer cells via the intracarotid artery. More importantly, F3.CD-TK cells in the presence of prodrugs 5-FC and GCV decreased tumor size and considerably prolonged animal survival. The results of the present study indicate that the dual suicide gene–engineered, NSC-based treatment strategy might offer a new promising therapeutic modality for brain metastases.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Delattre JY, Krol G, Thaler HT, Posner JB . Distribution of brain metastases. Arch Neurol 1988; 45: 741–744.

    Article  CAS  PubMed  Google Scholar 

  2. Yazawa K, Fisher WE, Brunicardi FC . Current progress in suicide gene therapy for cancer. World J Surg 2002; 26: 783–789.

    Article  PubMed  Google Scholar 

  3. Niculescu-Duvaz I, Springer CJ . Introduction to the background, principles, and state of the art in suicide gene therapy. Mol Biotechnol 2005; 30: 71–88.

    Article  CAS  PubMed  Google Scholar 

  4. Egami T, Ohuchida K, Miyoshi K, Mizumoto K, Onimaru M, Toma H et al. Chemotherapeutic agents potentiate adenoviral gene therapy for pancreatic cancer. Cancer Sci 2009; 100: 722–729.

    Article  CAS  PubMed  Google Scholar 

  5. Shimato S, Natsume A, Takeuchi H, Wakabayashi T, Fujii M, Ito M et al. Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma. Gene Therapy 2007; 14: 1132–1142.

    Article  CAS  PubMed  Google Scholar 

  6. Ito S, Natsume A, Shimato S, Ohno M, Kato T, Chansakul P et al. Human neural stem cells transduced with IFN-beta and cytosine deaminase genes intensify bystander effect in experimental glioma. Cancer Gene Ther 17: 299–306.

    Article  PubMed  Google Scholar 

  7. Vermes A, van Der Sijs H, Guchelaar HJ . Flucytosine: correlation between toxicity and pharmacokinetic parameters. Chemotherapy 2000; 46: 86–94.

    Article  CAS  PubMed  Google Scholar 

  8. Vermes A, Guchelaar HJ, Dankert J . Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J Antimicrob Chemother 2000; 46: 171–179.

    Article  CAS  PubMed  Google Scholar 

  9. Kievit E, Bershad E, Ng E, Sethna P, Dev I, Lawrence TS et al. Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts. Cancer Res 1999; 59: 1417–1421.

    CAS  PubMed  Google Scholar 

  10. Miller WH, Miller RL . Phosphorylation of acyclovir (acycloguanosine) monophosphate by GMP kinase. J Biol Chem 1980; 255: 7204–7207.

    CAS  PubMed  Google Scholar 

  11. Uckert W, Kammertons T, Haack K, Qin Z, Gebert J, Schendel DJ et al. Double suicide gene (cytosine deaminase and herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo. Hum Gene Ther 1998; 9: 855–865.

    Article  CAS  PubMed  Google Scholar 

  12. Lee HJ, Kim KS, Kim EJ, Lee KH, Choi HB, Park IH et al. Brain transplantation of human neural stem cells promotes functional recovery in mouse intracerebral hemorrhage stroke model. Stem Cells 2007; 25: 211–224.

    Article  Google Scholar 

  13. Kim SU, Nagai A, Nakagawa E, Choi HB, Bang JH, Lee HJ et al. Production and characterization of immortal human neural stem cell line with multipotent differentiation property. Methods Mol Biol 2008; 438: 103–121.

    Article  CAS  PubMed  Google Scholar 

  14. Gutova M, Najbauer J, Chen MY, Potter PM, Kim SU, Aboody KS . Therapeutic targeting of melanoma cells using neural stem cells expressing carboxylesterase, a CPT-11 activating enzyme. Curr Stem Cell Res Ther 5: 273–276.

    Article  CAS  Google Scholar 

  15. Kim YG, Bi W, Feliciano ES, Drake RR, Stambrook PJ . Ganciclovir-mediated cell killing and bystander effect is enhanced in cells with two copies of the herpes simplex virus thymidine kinase gene. Cancer Gene Ther 2000; 7: 240–246.

    Article  CAS  PubMed  Google Scholar 

  16. Rogulski KR, Wing MS, Paielli DL, Gilbert JD, Kim JH, Freytag SO . Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization. Hum Gene Ther 2000; 11: 67–76.

    Article  CAS  PubMed  Google Scholar 

  17. Toda M, Martuza RL, Rabkin SD . Combination suicide/cytokine gene therapy as adjuvants to a defective herpes simplex virus-based cancer vaccine. Gene Therapy 2001; 8: 332–339.

    Article  CAS  PubMed  Google Scholar 

  18. Kim SU . Neural stem cell-based gene therapy for brain tumors. Stem Cell Rev 7: 130–140.

    Article  Google Scholar 

  19. Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA 2000; 97: 12846–12851.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Aboody KS, Najbauer J, Danks MK . Stem and progenitor cell-mediated tumor selective gene therapy. Gene Therapy 2008; 15: 739–752.

    Article  CAS  PubMed  Google Scholar 

  21. Muller FJ, Snyder EY, Loring JF . Gene therapy: can neural stem cells deliver? Nat Rev Neurosci 2006; 7: 75–84.

    Article  PubMed  Google Scholar 

  22. Tang Y, Shah K, Messerli SM, Snyder E, Breakefield X, Weissleder R . In vivo tracking of neural progenitor cell migration to glioblastomas. Hum Gene Ther 2003; 14: 1247–1254.

    Article  CAS  PubMed  Google Scholar 

  23. Joo KM, Park IH, Shin JY, Jin J, Kang BG, Kim MH et al. Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases. Mol Ther 2009; 17: 570–575.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Kim SU, Jeung EB, Kim YB, Cho MH, Choi KC . Potential tumor-tropic effect of genetically engineered stem cells expressing suicide enzymes to selectively target invasive cancer in animal models. Anticancer Res 31: 1249–1258.

  25. Ushio Y, Chernik NL, Shapiro WR, Posner JB . Metastatic tumor of the brain: development of an experimental model. Ann Neurol 1977; 2: 20–29.

    Article  CAS  PubMed  Google Scholar 

  26. Springer CJ, Niculescu-Duvaz I . Prodrug-activating systems in suicide gene therapy. J Clin Invest 2000; 105: 1161–1167.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to A Natsume or S U Kim.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, C., Natsume, A., Lee, H. et al. Neural stem cell-based dual suicide gene delivery for metastatic brain tumors. Cancer Gene Ther 19, 796–801 (2012). https://doi.org/10.1038/cgt.2012.63

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cgt.2012.63

Keywords

This article is cited by

Search

Quick links